Gandeeva Therapeutics
PrivateLast Round
Series A
Jan 13, 2022
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gandeeva Therapeutics is a biotechnology company that leverages cryogenic electron microscopy and machine learning to develop novel therapeutics targeting protein-protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gandeeva Therapeutics Comparables
Compare Gandeeva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 81% | |
| Iambic Therapeutics | 80% | |
| Health Technology Innovations, Inc. | 78% | |
Gandeeva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 13, 2022 |
Key People
Founding team and executive leadership
Gandeeva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series A |
| Air Street Capital | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| Amgen Ventures | Series A |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 94% MoM, reaching 1.3K.
- Jan 13, 2022
$40M round led by Lux Capital and Leaps by Bayer.
Gandeeva Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gandeeva Therapeutics's valuation, stock price, and market status.